Company / Working Capital
Altimmune, Inc. Working Capital History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$263.2M
FY2025
5-year range
$126.8M / $263.2M
FY2021-FY2025
Trend
+107.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from $15M in FY2011 to $263M in FY2025.
Based on SEC 10-K filings.
$263M in FY2025 with a 5-year CAGR of +3.8%.
Improved from $197M to $263M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- +14.4%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +3.8%, indicating consistent growth.
- In FY2025, working capital increased 107.6% year-over-year.
- Lowest working capital in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $263.2M | +107.6% |
| FY2024 | $126.8M | -35.8% |
| FY2023 | $197.5M | +12.4% |
| FY2022 | $175.8M | -5.4% |
| FY2021 | $185.9M | -14.8% |
| FY2020 | $218.2M | +515.2% |
| FY2019 | $35.5M | +1.8% |
| FY2018 | $34.8M | +77.5% |
| FY2017 | $19.6M | +30.9% |
| FY2011 | $15.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026